+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infection Surveillance Solutions Market Share, Size, Trends, Industry Analysis Report, By Product and Services; By Infection Type; By End-Use; By Regions; Segment Forecast, 2021 - 2028

  • PDF Icon

    Report

  • 115 Pages
  • May 2021
  • Region: Global
  • Polaris Market Research
  • ID: 5397058
The global infection surveillance solutions market size is expected to reach USD 1.29 billion by 2028 according to this new study. The report “Infection Surveillance Solutions Market Share, Size, Trends, Industry Analysis Report, By Product and Services (Software, {On-premise, Web-based}, and Services); By Infection Type (Surgical Site Infections, Blood Stream Infections, Urinary Tract Infections); By End-Use; By Regions; Segment Forecast, 2021-2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

According to the estimates of the CDC, annually more than 23,000 people die from infection from drug-resistant bacteria and make sick around 2 million people in the - U.S alone. California Department of Public Health (CDPH), in 2016, reported around 18,924 hospital-acquired infection cases in 400 acute care hospitals.

Moreover, according to the market statistics published by the European Commission (EC) approximately, 25,000 individuals die suffering from antibiotic-resistant bacteria, and it is being reported that, by 2050, it would increase to 10 million annual deaths. The global rise in the number of surgeries being performed in the year has led to the increased patient stays in the hospitals or any other healthcare facility.

Based on this assumption, it is presumed that increase in the average length of hospital stay will expose them to HAIs, and the number of patients acquiring such infections is bound to increase. Moreover, the purchasing power capacity of hospitals and growing expenditure on healthcare are also projected to drive surveillance solutions market demand.

However, the Asia Pacific market is projected to witness the highest market growth rate over the surveillance solutions study period. This is due to gradually improving medical infrastructure, the positive intent of the government in addressing the issue, and booming medical tourism in South Asian countries.

However, the high cost of installing systems, their maintenance, and the unavailability of a skilled workforce is likely to hamper the region’s market growth for surveillance solutions. Market participants such Baxter International Inc.; Premier Inc.; Becton, Dickinson and Company; Wolters Kluwer N.V; RL Solutions; Gojo Industries; and Truven Health Analytics (An IBM Company).

The publisher has segmented the infection surveillance solutions market report on the basis of product and services, infection type, end-use, and region:


Infection Surveillance Solutions, Product and Services Outlook (Revenue-USD Million, 2016-2028)


  • Software
  • On-premise
  • Web-based
  • Services

Infection Surveillance Solutions, Infection Type Outlook (Revenue-USD Million, 2016-2028)


  • Surgical Site Infections (SSI)
  • Blood Stream Infections (BSI)
  • Urinary Tract Infections (UTI)
  • Others

Infection Surveillance Solutions, End-Use Outlook (Revenue-USD Million, 2016-2028)


  • Long Term Care Facilities
  • Hospitals
  • Others (Clinics, and Ambulatory Surgical Centers)

Infection Surveillance Solutions, by Regional Outlook (Revenue-USD Million, 2016-2028)


  • North America
  • U.S
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
Frequently Asked Questions about the Infection Surveillance Solutions Market

What is the estimated value of the Infection Surveillance Solutions Market?

The Infection Surveillance Solutions Market was estimated to be valued at $477.8 Million in 2021.

What is the growth rate of the Infection Surveillance Solutions Market?

The growth rate of the Infection Surveillance Solutions Market is 15.2%, with an estimated value of $1290 Million by 2028.

What is the forecasted size of the Infection Surveillance Solutions Market?

The Infection Surveillance Solutions Market is estimated to be worth $1290 Million by 2028.

Who are the key companies in the Infection Surveillance Solutions Market?

Key companies in the Infection Surveillance Solutions Market include Baxter International Inc., Premier Inc., Becton, Dickinson and Company, Wolters Kluwer N.V, RL Solutions and and Truven Health Analytics (An IBM Company)..

Table of Contents

1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Product and Services
3.2.1. Primary Product and Services
3.2.2. Secondary Product and Services
4. Infection Surveillance Solutions Market Insights
4.1. Infection Surveillance Solutions - Industry snapshot
4.2. Infection Surveillance Solutions Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Increasing prevalence of hospital acquired infections
4.2.1.2. Anti-microbial resistance
4.2.2. Restraints and Challenges
4.2.2.1. High cost of device installations
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Medium)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Medium)
4.3.4. Threat of Substitute (Medium)
4.3.5. Rivalry among existing firms (High)
4.4. PESTLE Analysis
4.5. Infection Surveillance Solutions Market Industry trends
4.6. COVID-19 Impact Analysis
5. Infection Surveillance Solutions Market Assessment by Product and Services
5.1. Key Findings
5.2. Introduction
5.2.1. Global Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
5.3. Software
5.3.1. Global Infection Surveillance Solutions Market, by Software, by Region, 2016 - 2028 (USD Million)
5.3.2. On-Premise
5.3.2.1. On-Premise Software Market, by Region, 2016 - 2028 (USD Million)
5.3.3. Web-Based
5.3.3.1. Web-Based Software Market, by Region, 2016 - 2028 (USD Million)
5.4. Services
5.4.1. Global Infection Surveillance Solutions Market, by Services, by Region, 2016 - 2028 (USD Million)
6. Global Infection Surveillance Solutions Market, by Infection Type
6.1. Key Findings
6.2. Introduction
6.2.1. Global Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
6.3. Surgical Site Infections (SSI)
6.3.1. Global Infection Surveillance Solutions Market, by Surgical Site Infections (SSI), By Region, 2016 - 2028 (USD Million)
6.4. Blood Stream Infections (BSI)
6.4.1. Global Infection Surveillance Solutions Market, by Blood Stream Infections (BSI), by Region, 2016 - 2028 (USD Million)
6.5. Urinary Tract Infections (UTI)
6.5.1. Global Infection Surveillance Solutions Market, by Urinary Tract Infections (UTI), by Region, 2016 - 2028 (USD Million)
7. Infection Surveillance Solutions Market Assessment by End Use
7.1. Key Findings
7.2. Introduction
7.2.1. Global Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
7.3. Long Term Care Facilities
7.3.1. Global Infection Surveillance Solutions Market, by Long Term Care Facilities, by Region, 2016 - 2028 (USD Million)
7.4. Hospitals
7.4.1. Global Infection Surveillance Solutions Market, by Hospitals, by Region, 2016 - 2028 (USD Million)
7.5. Others
7.5.1. Global Infection Surveillance Solutions Market, by Others, by Region, 2016 - 2028 (USD Million)
8. Infection Surveillance Solutions Market Assessment by Geography
8.1. Key findings
8.2. Introduction
8.2.1. Infection Surveillance Solutions Market Assessment, By Geography, 2016 - 2028 (USD Million)
8.3. Infection Surveillance Solutions Market - North America
8.3.1. North America: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.3.2. North America: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.3.3. North America: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.3.4. Infection Surveillance Solutions Market - U.S.
8.3.4.1. U.S.: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.3.4.2. U.S.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.3.4.3. U.S.: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.3.5. Infection Surveillance Solutions Market - Canada
8.3.5.1. Canada: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.3.5.2. Canada.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.3.5.3. Canada: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.4. Infection Surveillance Solutions Market - Europe
8.4.1. Europe: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.4.2. Europe.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.4.3. Europe: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.4.4. Infection Surveillance Solutions Market - UK
8.4.4.1. UK: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.4.4.2. UK.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.4.4.3. UK: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.4.5. Infection Surveillance Solutions Market - France
8.4.5.1. France: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.4.5.2. France.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.4.5.3. France: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.4.6. Infection Surveillance Solutions Market - Germany
8.4.6.1. Germany: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.4.6.2. Germany.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.4.6.3. Germany: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.4.7. Infection Surveillance Solutions Market - Italy
8.4.7.1. Italy: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.4.7.2. Italy.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.4.7.3. Italy: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.4.8. Infection Surveillance Solutions Market - Spain
8.4.8.1. Spain: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.4.8.2. Spain.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.4.8.3. Spain: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.4.9. Infection Surveillance Solutions Market - Netherlands
8.4.9.1. Netherlands: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.4.9.2. Netherlands.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.4.9.3. Netherlands: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.4.10. Infection Surveillance Solutions Market - Austria
8.4.10.1. Austria: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.4.10.2. Austria.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.4.10.3. Austria: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.5. Infection Surveillance Solutions Market - Asia-Pacific
8.5.1. Asia Pacific: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.5.2. Asia Pacific.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.5.3. Asia Pacific: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.5.4. Infection Surveillance Solutions Market - China
8.5.4.1. China: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.5.4.2. China.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.5.4.3. China: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.5.5. Infection Surveillance Solutions Market - India
8.5.5.1. India: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.5.5.2. India.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.5.5.3. India: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.5.6. Infection Surveillance Solutions Market - Malaysia
8.5.6.1. Malaysia: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.5.6.2. Malaysia.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.5.6.3. Malaysia: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.5.7. Infection Surveillance Solutions Market - Japan
8.5.7.1. Japan: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.5.7.2. Japan.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.5.7.3. Japan: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.5.8. Infection Surveillance Solutions Market - Indonesia
8.5.8.1. Indonesia: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.5.8.2. Indonesia.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.5.8.3. Indonesia: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.5.9. Infection Surveillance Solutions Market - Australia
8.5.9.1. Australia: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.5.9.2. Australia.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.5.9.3. Australia: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.6. Infection Surveillance Solutions Market - Middle East & Africa
8.6.1. Middle East & Africa: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.6.2. Middle East & Africa.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.6.3. Middle East & Africa: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.6.4. Infection Surveillance Solutions Market - Saudi Arabia
8.6.4.1. Saudi Arabia: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.6.4.2. Saudi Arabia.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.6.4.3. Saudi Arabia: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.6.5. Infection Surveillance Solutions Market - UAE
8.6.5.1. UAE: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.6.5.2. UAE.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.6.5.3. UAE: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.6.6. Infection Surveillance Solutions Market - Israel
8.6.6.1. Israel: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.6.6.2. Israel.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.6.6.3. Israel: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.6.7. Infection Surveillance Solutions Market - South Africa
8.6.7.1. South Africa: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.6.7.2. South Africa.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.6.7.3. South Africa: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.7. Infection Surveillance Solutions Market - Latin America
8.7.1. Latin America: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.7.2. Latin America.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.7.3. Latin America: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.7.4. Infection Surveillance Solutions Market - Mexico
8.7.4.1. Mexico: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.7.4.2. Mexico.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.7.4.3. Mexico: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.7.5. Infection Surveillance Solutions Market - Brazil
8.7.5.1. Brazil: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.7.5.2. Brazil.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.7.5.3. Brazil: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
8.7.6. Infection Surveillance Solutions Market - Argentina
8.7.6.1. Argentina: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
8.7.6.2. Argentina.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
8.7.6.3. Argentina: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
9.1.1. Expansion
9.1.2. Acquisition
9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
10.1. Becton, Dickinson and Company
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product & Services Benchmarking
10.1.4. Recent Development
10.2. Premier Inc.
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product & Services Benchmarking
10.2.4. Recent Development
10.3. Wolters Kluwer N.V.
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product & Services Benchmarking
10.3.4. Recent Development
10.4. Baxter International Inc.
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product & Services Benchmarking
10.4.4. Recent Development
10.5. Gojo Industries, Inc.
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product & Services Benchmarking
10.5.4. Recent Development
10.6. RL Solutions
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product & Services Benchmarking
10.6.4. Recent Development
10.7. Truven Health Analytics (An IBM Company)
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product & Services Benchmarking
10.7.4. Recent Development
10.8. DEB Group Ltd.
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product & Services Benchmarking
10.8.4. Recent Development
10.9. Hygreen, Inc.
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product & Services Benchmarking
10.9.4. Recent Development
10.10. Atlas Medical Software
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product & Services Benchmarking
10.10.4. Recent Development
List of Tables
Table 1. Global Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 2. Global Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 3. Global Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 4. Infection Surveillance Solutions Market Assessment, By Geography, 2016 - 2028 (USD Million)
Table 5. North America: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 6. North America: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 7. North America: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 8. U.S.: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 9. U.S.: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 10. U.S.: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 11. Canada: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 12. Canada: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 13. Canada: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 14. Europe: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 15. Europe: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 16. Europe: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 17. UK: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 18. UK: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 19. UK: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 22. France: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 24. Germany: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 25. Germany: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 26. Italy: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 27. Italy: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 28. Italy: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 29. Spain: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 30. Spain: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 31. Spain: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 32. Netherlands: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 33. Netherlands: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 34. Netherlands: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 35. Austria: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 36. Austria: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 37. Asia Pacific: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 38. Asia Pacific: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 39. Asia Pacific: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 40. China: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 41. China: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 42. China: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 43. India: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 44. India: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 45. India: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 46. Malaysia: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 47. Malaysia: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 48. Malaysia: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 49. Japan: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 50. Japan: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 51. Japan: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 52. Indonesia: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 53. Indonesia: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 54. Indonesia: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 55. Australia: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 56. Australia: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 57. Australia: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 58. Middle East & Africa: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 59. Middle East & Africa: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 60. Middle East & Africa: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 61. Saudi Arabia: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 62. Saudi Arabia: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 63. Saudi Arabia: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 64. UAE: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 65. UAE: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 66. UAE: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 67. Israel: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 68. Israel: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 69. Israel: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 70. South Africa: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 71. South Africa: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 72. South Africa: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 73. Latin America: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 74. Latin America: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 75. Latin America: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 76. Mexico: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 77. Mexico: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 78. Mexico: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 79. Brazil: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 80. Brazil: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 81. Brazil: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
Table 82. Argentina: Infection Surveillance Solutions Market, By Product and Services, 2016 - 2028 (USD Million)
Table 83. Argentina: Infection Surveillance Solutions Market, By Infection Type, 2016 - 2028 (USD Million)
Table 84. Argentina: Infection Surveillance Solutions Market, By End Use, 2016 - 2028 (USD Million)
List of Figures
Figure 1. Market Highlights (2020, Revenue)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top Down & Bottom Up Approach
Figure 4. Market by Geography
Figure 6. Porter’s Five Forces
Figure 7. Market by Product and Services
Figure 8. Global Infection Surveillance Solutions Market, By Product and Services, 2020 & 2028 (USD Million)
Figure 9. Market by Infection Type
Figure 10. Global Infection Surveillance Solutions Market, By Infection Type, 2020 & 2028 (USD Million)
Figure 11. Market by End Use
Figure 12. Global Infection Surveillance Solutions Market, By End Use, 2020 & 2028 (USD Million)
Figure 13. Infection Surveillance Solutions Market Assessment, By Geography, 2016 - 2028 (USD Million)
Figure 14. Strategic Analysis - Infection Surveillance Solutions Market

Companies Mentioned

  • Baxter International Inc.
  • Premier Inc.
  • Becton
  • Dickinson and Company
  • Wolters Kluwer N.V
  • RL Solutions
  • Gojo Industries
  • and Truven Health Analytics (An IBM Company).